Abbott

Abbott

Healthcare solutions in medical technology

About Abbott

Simplify's Rating
Why Abbott is rated
A
Rated A on Competitive Edge
Rated A on Growth Potential
Rated A on Rating Differentiation

Industries

Healthcare

Company Size

10,001+

Company Stage

IPO

Total Funding

N/A

Headquarters

Lake Bluff, Illinois

Founded

1888

Overview

Abbott Laboratories focuses on enhancing health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Abbott differentiates itself from competitors by emphasizing research and development to create accessible and affordable health solutions. The company's goal is to improve global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan that aims to enhance access to their technologies.

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased investment in microfluidics enhances Abbott's diagnostic capabilities and efficiency.
  • Inclusion in Abbott World Marathon Majors boosts brand visibility among health-conscious consumers.
  • Growing personalized medicine trend aligns with Abbott's advanced diagnostic solutions.

What critics are saying

  • Competition in microfluidics from Thermo Fisher may impact Abbott's diagnostics market share.
  • Resource diversion to marathons may affect innovation in core healthcare areas.
  • Rapid technological advancements may outpace Abbott's current product development cycles.

What makes Abbott unique

  • Abbott's diverse portfolio spans cardiovascular, diabetes, diagnostics, and neuromodulation sectors.
  • Commitment to sustainability with a 2030 plan enhances Abbott's global health impact.
  • Focus on R&D drives innovation in life-changing medical technologies.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$0

Below

Industry Average

Funded Over

1 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Company News

MarketBeat
Feb 15th, 2025
Root Financial Partners LLC Invests $228,000 in Abbott Laboratories (NYSE:ABT)

Root Financial Partners LLC invests $228,000 in Abbott Laboratories (NYSE:ABT).

MarketBeat
Jan 19th, 2025
Sax Wealth Advisors LLC Makes New $640,000 Investment in Abbott Laboratories (NYSE:ABT)

Sax Wealth Advisors LLC makes new $640,000 investment in Abbott Laboratories (NYSE:ABT).

MarketBeat
Jan 15th, 2025
Founders Grove Wealth Partners LLC Invests $471,000 in Abbott Laboratories (NYSE:ABT)

Founders Grove Wealth Partners LLC invests $471,000 in Abbott Laboratories (NYSE:ABT).

MarketBeat
Jan 15th, 2025
Cliftonlarsonallen Wealth Advisors LLC Invests $1.20 Million in Abbott Laboratories (NYSE:ABT)

Cliftonlarsonallen Wealth Advisors LLC invests $1.20 million in Abbott Laboratories (NYSE:ABT).

MarketBeat
Jan 7th, 2025
Range Financial Group LLC Invests $582,000 in Abbott Laboratories (NYSE:ABT)

Range Financial Group LLC invests $582,000 in Abbott Laboratories (NYSE:ABT).

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Abbott right now.

Find jobs on Simplify and start your career today

💡
We update Abbott's jobs every 8 hours, so check again soon! Browse all jobs →